The Role of Rescue Therapies in the Treatment of Severe ARDS

Respir Care. 2018 Jan;63(1):92-101. doi: 10.4187/respcare.05752. Epub 2017 Oct 24.

Abstract

ARDS is characterized by a non-cardiogenic pulmonary edema with bilateral chest radiograph opacities and hypoxemia refractory to oxygen therapy. It is a common cause of admission to the ICU due to hypoxemic respiratory failure requiring mechanical ventilation. Corticosteroids are not recommended in ARDS patients. Rescue therapies alleviate hypoxemia in patients unable to maintain reasonable oxygenation: recruitment maneuvers, prone positioning, inhaled nitric oxide, high-frequency oscillatory ventilation, and extracorporeal membrane oxygenation improve oxygenation, but their impact on mortality remains unproven. Restrictive fluid management seems to be a favorable strategy with no significant reduction in 60-d mortality. Future studies are needed to clarify the efficacy of these therapies on outcomes in patients with severe ARDS, and institution of these therapies may be considered on a case-by-case basis.

Keywords: extracorporeal membrane oxygenation; prone position; refractory hypoxemia; rescue therapies; severe ARDS; ventilatory setting.

Publication types

  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Bronchodilator Agents / therapeutic use
  • Critical Care / methods*
  • Extracorporeal Membrane Oxygenation / methods
  • Humans
  • Hypoxia / etiology
  • Hypoxia / therapy*
  • Nitric Oxide / therapeutic use
  • Prone Position
  • Respiration, Artificial / methods
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / therapy*
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy*

Substances

  • Adrenal Cortex Hormones
  • Bronchodilator Agents
  • Nitric Oxide